PMID- 36405109
OWN - NLM
STAT- MEDLINE
DCOM- 20221122
LR  - 20221122
IS  - 2219-2840 (Electronic)
IS  - 1007-9327 (Print)
IS  - 1007-9327 (Linking)
VI  - 28
IP  - 41
DP  - 2022 Nov 7
TI  - Feasibility of same-day discharge following endoscopic submucosal dissection for 
      esophageal or gastric early cancer.
PG  - 5957-5967
LID - 10.3748/wjg.v28.i41.5957 [doi]
AB  - BACKGROUND: Endoscopic submucosal dissection (ESD) is an established technique 
      for the treatment of early gastrointestinal neoplasia. Generally, multi-day (M-D) 
      admission is required for patients undergoing ESD due to potential complications. 
      AIM: To evaluate the feasibility of a same-day (S-D) discharge strategy for ESD 
      of the esophagus or stomach. METHODS: The data of patients who underwent 
      esophageal or gastric ESD were retrospectively collected from January 2018 to 
      December 2021 at Peking University Cancer Hospital. The propensity score matching 
      (PSM) method was applied to balance the unevenly distributed patient baseline 
      characteristics between the S-D and M-D groups. Intraoperative and postoperative 
      parameters were compared between the matched groups. RESULTS: Among the 479 
      patients reviewed, 470 patients, including 91 in the S-D group and 379 in the M-D 
      group, fulfilled the inclusion and exclusion criteria. Following PSM, 78 patients 
      in each group were paired using the 1:1 nearest available score match algorithm. 
      No significant difference was found between groups with respect to intraoperative 
      and postprocedural major adverse events (AEs). Tumor size, complete resection 
      rate, and procedural duration were comparable between the groups. The S-D group 
      demonstrated a significantly shorter length of hospital stay (P < 0.001) and 
      lower overall medical expenses (P < 0.001) compared with the M-D group. 
      CONCLUSION: The S-D discharge strategy may be feasible and effective for 
      esophagogastric ESD, and the procedural-related AEs can be managed successfully.
CI  - (c)The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights 
      reserved.
FAU - Wang, Jing
AU  - Wang J
AD  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of 
      Education), Endoscopy Center, Peking University Cancer Hospital & Institute, 
      Beijing 100142, China.
FAU - Li, Shi-Jie
AU  - Li SJ
AD  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of 
      Education), Endoscopy Center, Peking University Cancer Hospital & Institute, 
      Beijing 100142, China.
AD  - The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 
      832008, Xinjiang Uygur Autonomous Region, China.
FAU - Yan, Yan
AU  - Yan Y
AD  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of 
      Education), Endoscopy Center, Peking University Cancer Hospital & Institute, 
      Beijing 100142, China.
FAU - Yuan, Peng
AU  - Yuan P
AD  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of 
      Education), Endoscopy Center, Peking University Cancer Hospital & Institute, 
      Beijing 100142, China.
FAU - Li, Wei-Feng
AU  - Li WF
AD  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of 
      Education), Endoscopy Center, Peking University Cancer Hospital & Institute, 
      Beijing 100142, China.
FAU - Cao, Chang-Qi
AU  - Cao CQ
AD  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of 
      Education), Endoscopy Center, Peking University Cancer Hospital & Institute, 
      Beijing 100142, China.
FAU - Chen, Wei-Gang
AU  - Chen WG
AD  - The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 
      832008, Xinjiang Uygur Autonomous Region, China.
FAU - Chen, Ke-Neng
AU  - Chen KN
AD  - The First Department of Thoracic Surgery, Key Laboratory of Carcinogenesis and 
      Translational Research (Ministry of Education), Peking University Cancer Hospital 
      & Institute, Beijing 100142, China.
FAU - Wu, Qi
AU  - Wu Q
AD  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of 
      Education), Endoscopy Center, Peking University Cancer Hospital & Institute, 
      Beijing 100142, China. wuqi1973@bjmu.edu.cn.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - World J Gastroenterol
JT  - World journal of gastroenterology
JID - 100883448
SB  - IM
MH  - Humans
MH  - *Endoscopic Mucosal Resection/adverse effects/methods
MH  - Retrospective Studies
MH  - Patient Discharge
MH  - Feasibility Studies
MH  - Treatment Outcome
MH  - *Stomach Neoplasms/surgery/etiology
MH  - Esophagus/surgery
PMC - PMC9669832
OTO - NOTNLM
OT  - Adverse event
OT  - Early esophageal cancer
OT  - Early gastric cancer
OT  - Endoscopic submucosal dissection
OT  - Same-day surgery
COIS- Conflict-of-interest statement: All the authors report no relevant conflicts of 
      interest for this article.
EDAT- 2022/11/22 06:00
MHDA- 2022/11/23 06:00
PMCR- 2022/11/07
CRDT- 2022/11/21 03:50
PHST- 2022/07/26 00:00 [received]
PHST- 2022/09/15 00:00 [revised]
PHST- 2022/10/19 00:00 [accepted]
PHST- 2022/11/21 03:50 [entrez]
PHST- 2022/11/22 06:00 [pubmed]
PHST- 2022/11/23 06:00 [medline]
PHST- 2022/11/07 00:00 [pmc-release]
AID - 10.3748/wjg.v28.i41.5957 [doi]
PST - ppublish
SO  - World J Gastroenterol. 2022 Nov 7;28(41):5957-5967. doi: 
      10.3748/wjg.v28.i41.5957.